Detalhe da pesquisa
1.
New molecular targets in the treatment of rheumatoid arthritis.
Curr Opin Rheumatol
; 36(3): 235-240, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38165286
2.
Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells.
Cancer Immunol Immunother
; 73(2): 34, 2024 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38280067
3.
Siponimod Attenuates Neuronal Cell Death Triggered by Neuroinflammation via NFκB and Mitochondrial Pathways.
Int J Mol Sci
; 25(5)2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38473703
4.
CD13/Aminopeptidase N Is a Potential Therapeutic Target for Inflammatory Disorders.
J Immunol
; 204(1): 3-11, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31848300
5.
Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma.
Proc Natl Acad Sci U S A
; 116(9): 3695-3702, 2019 02 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30755532
6.
Interferon-stimulated GTPases in autoimmune and inflammatory diseases: promising role for the guanylate-binding protein (GBP) family.
Rheumatology (Oxford)
; 60(2): 494-506, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33159795
7.
Angiogenic and Arthritogenic Properties of the Soluble Form of CD13.
J Immunol
; 203(2): 360-369, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31189572
8.
Role of Complement in a Rat Model of Paclitaxel-Induced Peripheral Neuropathy.
J Immunol
; 200(12): 4094-4101, 2018 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29695418
9.
CD6 as a potential target for treating multiple sclerosis.
Proc Natl Acad Sci U S A
; 114(10): 2687-2692, 2017 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28209777
10.
CD318 is a ligand for CD6.
Proc Natl Acad Sci U S A
; 114(33): E6912-E6921, 2017 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28760953
11.
Rheumatoid arthritis - the challenge of heterogeneity.
Curr Opin Rheumatol
; 36(3): 201-202, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38517339
12.
IL-11 facilitates a novel connection between RA joint fibroblasts and endothelial cells.
Angiogenesis
; 21(2): 215-228, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29327326
13.
Targeting CD6 for the treatment of experimental autoimmune uveitis.
J Autoimmun
; 90: 84-93, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29472120
14.
Establishing clinical severity for PROMIS® measures in adult patients with rheumatic diseases.
Qual Life Res
; 27(3): 755-764, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28983738
15.
Transforming growth factor ß activated kinase 1: a potential therapeutic target for rheumatic diseases.
Rheumatology (Oxford)
; 56(7): 1060-1068, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27550296
16.
Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma.
Bioorg Med Chem Lett
; 27(8): 1744-1749, 2017 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28285914
17.
Plasma CXCL9 elevations correlate with chronic GVHD diagnosis.
Blood
; 123(5): 786-93, 2014 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24363401
18.
T cell subsets and their role in the pathogenesis of rheumatic disease.
Curr Opin Rheumatol
; 26(2): 204-10, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24445478
19.
Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury.
J Pharmacol Exp Ther
; 349(3): 480-6, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24706986
20.
Noxa in rheumatic diseases: present understanding and future impact.
Rheumatology (Oxford)
; 53(9): 1539-46, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24352336